Fujifilm India appoints Koji Wada as new Managing Director

Published On 2021-07-07 05:30 GMT   |   Update On 2021-07-07 12:50 GMT

New Delhi: Imaging technologies firm Fujifilm India on Tuesday said it has appointed Koji Wada as its new Managing Director.

The appointment is effective from June 29, 2021, Fujifilm India Pvt Ltd said in a statement.

Wada takes over from Haruto Iwata who moved to his new role as Managing Director for the Asia-Pacific region in Singapore, the statement added.

Wada will spearhead Fujifilm''s operations and business strategy in India. In his new role, he will be responsible for organisational growth and profitability with an integrated approach towards sales, marketing, and business policies, it added.

"As I transition into the new role, I am looking forward to collaborating with the teams across various divisions to take the company to newer heights. With India as a market thriving with opportunities, we will continue with our endeavour of Never Stop adding value to the lives of consumers & stakeholders," Wada said.

Read also: Fujifilm to invest Rs 1,450 crore for 100 health-screening centres in India

Wada has been associated with Fujifilm since 2001. He brings experience of over 20 years and before taking over his role as managing director, he was responsible for leading the medical business of the company in India as a General Manager, the statement said.

Read also: Fujifilm to restart clinical trial of Avigan for COVID-19 treatment: Report



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News